Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

IMPORTANCE: Stereotactic ablative radiotherapy (SABR) is first-line treatment for patients with early-stage non–small cell lung cancer (NSCLC) who cannot undergo surgery. However, up to 1 in 6 such patients will develop isolated local recurrence (iLR) or isolated regional recurrence (iRR). Little is...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Eric D., Sun, Bing, Feng, Lei, Verma, Vivek, Zhao, Lina, Gomez, Daniel R., Liao, Zhongxing, Jeter, Melenda, O’Reilly, Michael, Welsh, James W., Nguyen, Quynh-Nhu, Erasmus, Jeremy J., Eapen, George, Ahrar, Kamran, Antonoff, Mara B., Hahn, Stephen M., Heymach, John V., Rice, David C., Chang, Joe Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324276/
https://www.ncbi.nlm.nih.gov/pubmed/30646121
http://dx.doi.org/10.1001/jamanetworkopen.2018.1390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324276/
https://www.ncbi.nlm.nih.gov/pubmed/30646121
http://dx.doi.org/10.1001/jamanetworkopen.2018.1390

Ejemplares similares